Cefuroxime compared to piperacillin/tazobactam as empirical treatment of Escherichia coli bacteremia in a low Extended-spectrum beta-lactamase (ESBL) prevalence cohort

Overview of attention for article published in Infection and Drug Resistance, May 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 17 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 629 followers.

Cefuroxime compared to piperacillin/tazobactam as empirical treatment of Escherichia coli bacteremia in a low Extended-spectrum beta-lactamase (ESBL) prevalence cohort. https://t.co/u47KplTLeG

18 Jun 2019

Reply Repost Favourite

Cefuroxime compared to piperacillin/tazobactam as empirical treatment | IDR - Dove Medical Press https://t.co/s1Mp0z3rdV #cre #crkp #AMR

14 May 2019